We-Linking Raised Over CNY 10 Mn in Angel Round
Intraoperative Neurophysiological Monitoring Equipment Developer NeuroFlag Closed An Angel Round
IntoCare Zhang Hui: Ingenuity Forges Quality, Continuous Improvement Safeguards Lives
In 2024, nearly all medical enterprises are exploring overseas markets. This trend is driven by an anti-corruption wave within the medical industry, the demand for financing and initial public offerings, as well as challenges such as excess production capacity. Presently, venturing abroad has become an essential developmental path for medical device enterprises. Successfully entering foreign markets is not only a crucial means for the medical industry to achieve a second grow
May 09, 2024 12:18 PM
Innovative Drug Developer Rezu Bio Raised CNY 10 Mn in Series Pre-A
ZD Medtech Raised Over CNY 100 Mn in Series B
Smart Powered Bionic Prosthetic Star BionicM Nets Over CNY 10 Mn
Medical Technology Company MacroLux Nets Nearly CNY 100 Mn in Series A
China's First Modified New Drug of Docetaxel Successfully Went to the US
Feb 19, 2025 10:41 AM
The first batch of antigen testing agent boxes at the Shenzhen store of Da Shen Lin did not arrive. Wanfu biology was 19.3 yuan / time
Yuntianhua: the shareholder completed the reduction of 2% of the shares with the investment of Yuntianhua
Yifeng: Xiao Zaixiang, the Vice President, Intends to Sell Shares
China's New Energy Intelligent Vehicle Industry Chain Enterprises Have Opened a New Era
Feb 27, 2025 03:42 PM
AIEV Leads the Way into a New Era of Automotive Intelligence
Feb 27, 2025 03:27 PM
Witnessing History: The New Globalization Landscape of 2025 (Part II)
Feb 24, 2025 09:49 PM